A First Exploration of Health Impact Assessment of Chemical Exposure: Assigning Weights to Subclinical Effects Based on Animal Studies

REFERENCES

• Arnesen T and Kapiriri L. 2004. Can the value choices in DALYs influence global priority-setting? Health Policy 70(2):137–49
   PubMed Web of Science ®Google Scholar
• Axelrad DA, Baetcke K, Dockins C, et al. 2005. Risk assessment for benefits analysis: Framework for analysis of a thyroid-disrupting chemical. J. Toxicol. Environ. Health, Part A 68:837–55
   PubMed Web of Science ®Google Scholar
• Bottex B, Dorne JLCM, Carlander D, et al. 2008. Risk–benefit health assessment of food—Food fortification and nitrate in vegetables. Trends Food Sci Technol 19(supp 1):S113–9
   Google Scholar
• Buist HE, Von Bölcsházy GF, Dammann M, et al. 2009. Derivation of the minimal magnitude of the Critical Effect Size for continuous toxicological parameters from within-animal variation in control group data. Regul Toxicol Pharmacol 55:139–50
   PubMed Web of Science ®Google Scholar
• Cohen JT, Bellinger DC, Connor WE, et al. 2005. A quantitative risk–benefit analysis of changes in population fish consumption. Am J Prevent Med 29(4):325–34
   PubMed Web of Science ®Google Scholar
• Crettaz P, Pennington D, Rhomberg L, et al. 2002. Assessing human health response in life cycle assessment using ED10s and DALYs: Part 1—Cancer effects. Risk Anal 22(5):931–46
   PubMed Web of Science ®Google Scholar
• De Hollander AE, Melse JM, Lebret E, et al. 1999. An aggregate public health indicator to represent the impact of multiple environmental exposures. Epidemiology 10(5):606–17
   PubMed Web of Science ®Google Scholar
• Dekkers S, Telman J, Rennen MA, et al. 2006. Within-animal variation as an indication of the minimal magnitude of the critical effect size for continuous toxicological parameters applicable in the benchmark dose approach. Risk Anal 26(4):867–80
   PubMed Web of Science ®Google Scholar
• ECHA (European Chemicals Agency). 2008. Guidance on Socio-Economic Analysis—Restrictions. Guidance for the Implementation of REACH. Helsinki, Finland. Available at: http://echa.europa.eu/documents/10162/13641/sea_restrictions_en.pdf (accessed September 1, 2014)
   Google Scholar
• Evans GO (Ed.): 1996. Animal Clinical Chemistry—A Primer for Toxicologists, pp 1–224. Taylor & Francis, London, UK
   Google Scholar
• Fantke P, Friedrich R, and Jolliet O. 2012. Health impact and damage cost assessment of pesticides in Europe. Environ Internat 15(49):9–17
   Web of Science ®Google Scholar
• Franchini M, Guida A, Tufano A, et al. 2012. Air pollution, vascular disease and thrombosis: Linking clinical data and pathogenic mechanisms. J Thromb Haemost 10(12):2438–51
   PubMed Web of Science ®Google Scholar
• Gennings C, Ellis R, and Ritter JK. 2012. Linking empirical estimates of body burden of environmental chemicals and wellness using NHANES data. Environ Internat 39(1):56–65
   PubMed Web of Science ®Google Scholar
• Hammitt JK. 2008. Valuing “Lives saved” vs. “Life-years saved”. Harvard center for risk analysis 16 (1). Available at http://www.stat.columbia.edu/∼gelman/stuff_for_blog/hammitt.pdf (accessed May 2014)
   Google Scholar
• Havelaar AH, De Hollander AE, Teunis PF, et al. 2000. Balancing the risks and benefits of drinking water disinfection: Disability adjusted life-years on the scale. Environ. Health Perspect 108(4):315–21
   PubMed Web of Science ®Google Scholar
• Hoekstra J, Hart A, Owen H, et al. 2013. Fish, contaminants and human health; Quantifying and weighing benefits and risks. Food Chem Toxicol 54:18–29
   PubMed Web of Science ®Google Scholar
• Hofstetter P and Hammitt JK. 2002. Selecting human health metrics for environmental decision-support tools. Risk Anal 22(5):965–83
   PubMed Web of Science ®Google Scholar
• Karabelas AJ, Plakas KV, Solomou ES, et al. 2009. Impact of European legislation on marketed pesticides—A view from the standpoint of health impact assessment studies. Environ Internat 35:1096–107
   PubMed Web of Science ®Google Scholar
• Kelly E, Carls GS, Lenhart G, et al. 2010. The Novartis Health Index: A method for valuing the economic impact of risk reduction in a workforce. JOEM 52(5):528–35
   Google Scholar
• Knol AB, Briggs DJ, and Lebret E. 2010. Assessment of complex environmental health problems: Framing the structures and structuring the frameworks. Sci Total Environ 408(14):2785–94
   PubMed Web of Science ®Google Scholar
• McAlearney AS, Schweikhart SB, and Pathak DS. 1999. Quality-adjusted life-years and other health indices: A comparative analysis. Clin Ther 21(9):1605–29
   PubMed Web of Science ®Google Scholar
• McLeod C, Bagust A, Boland A, et al. 2007. Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: A systematic review and economic evaluation. Health Technol Assess 11(28):1–158
   Web of Science ®Google Scholar
• Melse JM, Essink-Bot ML, Kramers PG, et al. 2000. A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Am J Public Health 90(8):1241–7
   PubMed Web of Science ®Google Scholar
• Mindell JS, Boltong A, and Forde I. 2008. A review of health impact assessment frameworks. Public Health 122:1177–87
   PubMed Web of Science ®Google Scholar
• Murray CJ and Lopez AD. 1997. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 17(349) (9063):1436–42
   Web of Science ®Google Scholar
• Newsome R, Tran N, Paoli GM, et al. 2009. Development of a risk-ranking framework to evaluate potential high-threat microorganisms, toxins, and chemicals in food. J Food Sci 74(2):R39–45
   PubMed Web of Science ®Google Scholar
• NTP (National Toxicology Program). 2004. NTP Technical Report on the Toxicity Studies of 1,1,2,2-Tetrachloroethane (CAS No. 79-34-5) Administered in Microcapsules in Feed to F344/N Rats and B6C3F₁ Mice. Tox 49. Research Triangle Park, NC, USA
   Google Scholar
• NTP 2006. NTP Technical Report on the Comparative Toxicity Studies of Allyl Acetate, Allyl Alcohol, and Acrolein (CAS No. 591-87-7, 107-18-6, and 107-02-8). Administered by Gavage to F344/N Rats and B6C3F₁ Mice. Tox 48. Research Triangle Park, NC, USA
   Google Scholar
• Pennington D, Crettaz P, Tauxe A, et al. 2002. Assessing human health response in life cycle assessment using ED10s and DALYs: Part 2—Noncancer effects. Risk Anal 22(5):947–63
   PubMed Web of Science ®Google Scholar
• Petticrew M, Cummins S, Sparks L, et al. 2007. Validating health impact assessment: Prediction is difficult (especially about the future). Environ Impact Assess Review 27:101–7
   Web of Science ®Google Scholar
• RIVM (National Institute for Public Health and the Environment). 2005. Gezondheidseffecten en ziektelast door blootstelling aan stoffen op de werkplek - een verkennend onderzoek. RIVM Report 320100001 (in Dutch). Bitlhoven, The Netherlands
   Google Scholar
• RIVM. 2006. Factsheets for the (Eco)Toxicological Risk Assessment Strategy of the National Institute for Public Health and the Environment, Part VI. RIVM Report 601516014, Bilthoven, The Netherlands
   Google Scholar
• RIVM. 2008. Health Impact Assessment Of Policy Measures for Chemicals in Non-Food Consumer Products. RIVM report 320015001, Bilthoven, The Netherlands
   Google Scholar
• RIVM. 2012. From Risk Assessment to Environmental Impact Assessment of Chemical Substances: Methodology Development to be Used in Socio-Economic Analysis for REACH. RIVM Report 601353002, Bilthoven, The Netherlands
   Google Scholar
• RIVM-TNO. 2006a. Historical Versus Recent Exposure to Chemicals at the Workplace as the Cause of Health Effects and Burden of Disease. RIVM Report 320506001; TNO report V7147. RIVM, Bilthoven, The Netherlands. TNO (Netherlands Organisation for Applied Scientific Research), Zeist, The Netherlands
   Google Scholar
• RIVM-TNO. 2006b. Identification of Important Occupations and Chemicals in the Development of Diseases and the Burden of Diseases Due to Exposure at the Workplace. RIVM Report 320506002; TNO report V7148. RIVM, Bilthoven, The Netherlands. TNO, Zeist, The Netherlands
   Google Scholar
• State of Victoria, Department of Human Services. 2005. Victorian Burden of Disease Study Mortality and Morbidity in 2001. Available at http://www.health.vic.gov.au/healthstatus/downloads/bod_2001.pdf (accessed May 2014)
   Google Scholar
• Stouthard MEA, Essink-Bot ML, and Bonsel GJ. 2000. Disability weights for diseases. A modified protocol and results for a Western European region. Eur J Public Health 10:24–30
   Web of Science ®Google Scholar
• Travlos GS, Morris RW, Elwell MR, et al. 1996. Frequency and relationships of clinical chemistry and liver and kidney histopathology findings in 13-week toxicity studies in rats. Toxicology 107(1):17–29
   PubMed Web of Science ®Google Scholar
• USEPA (US Environmental Protection Agency). 2014. Available at http://www.epa.gov/ttn/atw/toxsource/noncarcinogens.html (accessed January 2014)
   Google Scholar
• Van der Voet H, van der Heijden GW, Bos PM, et al. 2009. A model for probabilistic health impact assessment of exposure to food chemicals. Food Chem Toxicol 47(12):2926–40
   PubMed Web of Science ®Google Scholar
• Whitehead SJ and Ali S. 2010. Health outcomes in economic evaluation: The QALY and utilities. British Med Bull 96:5–21
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organisation). 1968. Nutritional Anaemias. Technical Report Series No. 405. Geneva, Switzerland
   Google Scholar
• WHO. 2001. Iron Deficiency Anaemia Assessment, Prevention, and Control. A Guide for Programme Managers. WHO/NHD/01.3. Geneva, Switzerland
   Google Scholar
• WHO. 2004. Available at http://www.who.int/ipcs/publications/methods/harmonization/definitions_terms/en/ (accessed January 2014)
   Google Scholar
• Zeilmaker MJ, Hoekstra J, van Eijkeren JC, et al. 2013. Fish consumption during child bearing age: A quantitative risk-benefit analysis on neurodevelopment. Food Chem Toxicol 254:30–4
   Web of Science ®Google Scholar